Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Myelodysplastic Syndromes 65Lymphoma, Non-Hodgkin 51Leukemia, Lymphocytic, Chronic, B-Cell 51Hodgkin Disease 47Leukemia 44Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Multiple Myeloma 40Lymphoma, Mantle-Cell 37Lymphoma, Follicular 36Myeloproliferative Disorders 34Lymphoma 34Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 32Lymphoma, Large B-Cell, Diffuse 29Leukemia, Myelomonocytic, Chronic 29Hematologic Neoplasms 25Congenital Abnormalities 24Lymphoma, Large-Cell, Immunoblastic 21Leukemia, Myeloid, Accelerated Phase 21Leukemia, Biphenotypic, Acute 20Primary Myelofibrosis 19Leukemia, Myeloid, Chronic-Phase 19Anemia, Refractory, with Excess of Blasts 19Waldenstrom Macroglobulinemia 18Blast Crisis 17Dendritic Cell Sarcoma, Interdigitating 16Lymphoma, Large-Cell, Anaplastic 15Leukemia, Prolymphocytic 15

Interventions

Thiotepa 2Melphalan 2Cyclophosphamide 2fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Therapeutics 1Muromonab-CD3 1Immunotherapy 1Drug Therapy 1Busulfan 1Antilymphocyte Serum 1Antibodies 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Histiocytosis × Whole-Body Irradiation × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡